Susquehanna Fundamental Investments’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-15,600
Closed -$50K 1762
2021
Q2
$50K Buy
+15,600
New +$50K ﹤0.01% 1621